Abstract
The Women's Health Initiative (WHI) is an NIH-sponsored, multicenter effort to evaluate therapeutic interventions in postmenopausal women. The arm of the trial that randomly assigned 16,608 women to receive either placebo or conjugated estrogens (0.625 mg/day) plus medroxyprogesterone acetate (2.5 mg/day) was halted in 2002 because hormone recipients showed increased risks for breast cancer, stroke, and heart disease (Journal Watch Women's Health Aug 7 2002). Many publications now are in press reporting outcomes of this arm of the study. JWWH will …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
